ETFs that hold Alnylam Pharmaceuticals Inc
55 US listed ETFs hold Alnylam Pharmaceuticals Inc. FMED holds the most, at 2.80% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| FMED | Fidelity Disruptive Medicine ETF | 2.80% | May 31, 2026 |
| BBH | VanEck Biotech ETF | 2.69% | Sep 17, 2026 |
| GNMX | Corgi Genomics & Precision Medicine ETF | 2.64% | Sep 18, 2026 |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 2.48% | Sep 18, 2026 |
| IBB | iShares Biotechnology ETF | 2.36% | Sep 17, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 2.14% | Sep 19, 2026 |
| HTEC | ROBO Global(R) Healthcare Technology and Innovation ETF | 2.02% | Apr 30, 2026 |
| HELX | Franklin Genomic Advancements ETF | 1.98% | Jun 30, 2026 |
| BBP | Virtus Biotech ETF | 1.25% | Apr 30, 2026 |
| XBI | State Street SPDR S&P Biotech ETF | 0.81% | Sep 17, 2026 |
| TCAL | T. Rowe Price Capital Appreciation Premium Income ETF | 0.79% | Jun 30, 2026 |
| CGGR | Capital Group Growth ETF | 0.76% | May 31, 2026 |
| ILDR | First Trust Innovation Leaders ETF | 0.57% | Sep 18, 2026 |
| USMV | iShares MSCI USA Min Vol Factor ETF | 0.57% | Sep 17, 2026 |
| CGBL | Capital Group Core Balanced ETF | 0.51% | Jun 30, 2026 |
| VHT | Vanguard Health Care ETF | 0.45% | Aug 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.38% | Aug 31, 2026 |
| VO | Vanguard Morningstar Mid-Cap ETF | 0.31% | Aug 31, 2026 |
| WDNA | WisdomTree BioRevolution Fund | 0.29% | Jun 30, 2026 |
| ROCQ | JPMorgan Nasdaq Equity Premium Yield ETF | 0.25% | Jun 30, 2026 |
| FBCG | Fidelity Blue Chip Growth ETF | 0.23% | Apr 30, 2026 |
| JEPQ | JPMorgan Nasdaq Equity Premium Income ETF | 0.21% | Jun 30, 2026 |
| XIGV | Defiance US 100 Tech Ex Software ETF | 0.20% | Sep 21, 2026 |
| XT | iShares Future Exponential Technologies ETF | 0.19% | Sep 17, 2026 |
| QQA | 0.19% | Apr 30, 2026 | |
| CRTC | Xtrackers US National Critical Technologies ETF | 0.19% | May 31, 2026 |
| QVOL | Infrastructure Capital Nasdaq Option Income ETF | 0.18% | May 31, 2026 |
| QQQI | NEOS Nasdaq-100(R) High Income ETF | 0.17% | Jun 30, 2026 |
| IQQQ | ProShares Nasdaq-100 High Income ETF | 0.16% | May 31, 2026 |
| QQQ | Invesco QQQ Trust | 0.14% | Sep 19, 2026 |
| QQQM | Invesco NASDAQ 100 ETF | 0.14% | Sep 19, 2026 |
| QRMI | Global X NASDAQ 100 Risk Managed Income ETF | 0.14% | Sep 18, 2026 |
| QYLD | Global X NASDAQ 100 Covered Call ETF | 0.14% | Sep 18, 2026 |
| QYLG | Global X Nasdaq 100 Covered Call & Growth ETF | 0.14% | Sep 18, 2026 |
| SCHG | Schwab U.S. Large-Cap Growth ETF | 0.14% | May 31, 2026 |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.14% | Jun 30, 2026 |
| XQQI | NEOS Boosted Nasdaq-100(R) High Income ETF | 0.14% | Jun 30, 2026 |
| GPIQ | Goldman Sachs Nasdaq-100 Premium Income ETF | 0.11% | Jun 30, 2026 |
| USNZ | Xtrackers Net Zero Pathway Paris Aligned US Equity ETF | 0.11% | May 29, 2026 |
| GARP | iShares MSCI USA Quality GARP ETF | 0.11% | Sep 17, 2026 |
| VUG | Vanguard Morningstar Growth ETF | 0.10% | Aug 31, 2026 |
| IWF | iShares Russell 1000 Growth ETF | 0.10% | Sep 17, 2026 |
| VONG | Vanguard Russell 1000 Growth ETF | 0.10% | Aug 31, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.09% | May 31, 2026 |
| DFUS | Dimensional U.S. Equity Market ETF | 0.07% | Apr 30, 2026 |
| SCHX | Schwab U.S. Large-Cap ETF | 0.06% | May 31, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.06% | Jun 30, 2026 |
| IWB | iShares Russell 1000 ETF | 0.05% | Sep 17, 2026 |
| VTI | Vanguard Morningstar Total Stock Market ETF | 0.04% | Aug 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.04% | Sep 17, 2026 |
| URTH | iShares MSCI World ETF | 0.04% | Sep 17, 2026 |
| SPUT | Innovator Equity Premium Income - Daily PutWrite ETF | 0.03% | Apr 30, 2026 |
| ACWI | iShares MSCI ACWI ETF | 0.03% | Sep 17, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.03% | Aug 31, 2026 |
| DYNF | iShares U.S. Equity Factor Rotation Active ETF | 0.02% | Sep 17, 2026 |
What this counts
Alnylam Pharmaceuticals Inc (ticker ALNY) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding Alnylam Pharmaceuticals Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/alny/ Free to use with attribution; the underlying files are at Open data.